GlaxoSmithKline and Medtronic have provided capital to Saluda Medical, a medical device maker working on a spinal cord stimulator system.

The corporate venture fund, backed by the Blue Cross and Blue Shield Association, has raised an initial $10m for its new fund.

Cancer treatment developer Harpoon Therapeutics has closed a $45m series B round backed by investors including Taiho Pharmaceutical.

Dubbed Solve Ventures, the investment arm will focus on digital health and medical diagnostics technologies.

Irritable bowel syndrome treatment startup OrphoMed has completed a series A round co-led by Takeda Ventures and New Enterprise Associates.

WL Gore & Associates joined Asset Management Partners and JDRF to invest $10m in ViaCyte, a diabetes treatment company also backed by Johnson & Johnson.

WuXi AppTec took part in a round that Canbridge Life Sciences will put toward clinical trials of two cancer immunotherapies for use in its home country of China.

Corporate venturing units Lilly Asia Ventures and SR One have contributed to a series C round that will support development of TP's precision cancer drug.